Wilson celebrates the first U.S. patient to complete gene therapy for sickle cell, but says advocacy must continue.
It may be possible to collect nearly three times as many stem cells for sickle cell gene therapy with motixafortide than standard plerixafor.
A University of Rochester hospital will open a patient study comparing the efficacy of SCD treatments to help families in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback